Why U.S. pharma giants are betting bigger on China's innovation ecosystem?
By Qaiser Nawab | AzerNEWS | Guest columnist From AI-assisted high-complexity cardiovascular interventions, where digital algorithms pre-simulate intricate surgical workflows, accurately predict intraoperative risks, and tailor personalized treatment plans …